DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Goldmann L, Duan R, Kragh T. et al.
Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?.
Blood Adv 2019;
3 (23) 4021-4033
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.